Lupin Limited (NSE:LUPIN)
2,098.80
+6.80 (0.33%)
Dec 5, 2025, 3:29 PM IST
Lupin Market Cap
Lupin has a market cap or net worth of 955.52 billion as of December 5, 2025. Its market cap has increased by 4.03% in one year.
Market Cap
955.52B
Enterprise Value
955.83B
Revenue
247.51B
Ranking
n/a
PE Ratio
22.09
Stock Price
2,098.80
Market Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 955.52B, an increase of 95,630.59%. That is a compound annual growth rate of 29.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 955.52B | -10.91% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | 442.95B | 27.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.32T |
| Divi's Laboratories | 1.70T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.04T |
| Zydus Lifesciences | 948.58B |
| Mankind Pharma | 914.84B |
| Aurobindo Pharma | 705.79B |
| Fortis Healthcare | 691.35B |